(+)-schisandrin B multiple interactions ISO RGD:619800 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of VEGFC mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of VEGFC mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VEGFC mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:732214 6480464 Dinitrochlorobenzene results in increased expression of VEGFC mRNA CTD PMID:25617811 17beta-estradiol multiple interactions ISO RGD:732214 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of VEGFC mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:732214 6480464 Estradiol results in decreased expression of VEGFC mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of VEGFC mRNA] CTD PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VEGFC mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:619800 6480464 Tetrachlorodibenzodioxin results in increased expression of VEGFC mRNA CTD PMID:20558275 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of VEGFC mRNA CTD PMID:12167310 more ... 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:732214 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression ISO RGD:619800 6480464 2, 4-dinitrotoluene affects the expression of VEGFC mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:619800 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:732214 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VEGFC mRNA CTD PMID:28628672 4'-epidoxorubicin multiple interactions ISO RGD:732214 6480464 VEGFC mRNA results in increased susceptibility to [Paclitaxel co-treated with Epirubicin co-treated with CMF regimen] CTD PMID:23146280 4,4'-sulfonyldiphenol affects expression EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of VEGFC mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of VEGFC mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:619800 6480464 Propylthiouracil results in increased expression of VEGFC mRNA CTD PMID:24780913 6-propyl-2-thiouracil decreases expression ISO RGD:619800 6480464 Propylthiouracil results in decreased expression of VEGFC mRNA CTD PMID:25825206 8-Br-cAMP increases expression ISO RGD:732214 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VEGFC mRNA CTD PMID:22079614 9-cis-retinoic acid decreases expression ISO RGD:732214 6480464 Alitretinoin results in decreased expression of VEGFC mRNA CTD PMID:15982314 aflatoxin B1 increases expression ISO RGD:732214 6480464 Aflatoxin B1 results in increased expression of VEGFC mRNA CTD PMID:22100608 all-trans-4-oxoretinoic acid decreases expression ISO RGD:732214 6480464 4-oxoretinoic acid results in decreased expression of VEGFC mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:732214 6480464 Tretinoin results in decreased expression of VEGFC mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of VEGFC mRNA CTD PMID:16788091 all-trans-retinoic acid increases expression ISO RGD:732214 6480464 Tretinoin metabolite results in increased expression of VEGFC mRNA CTD PMID:15982314 AM-251 multiple interactions ISO RGD:732214 6480464 AM 251 inhibits the reaction [arachidonyl-2-chloroethylamide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased secretion of VEGFC protein]] CTD PMID:26467187 ammonium chloride affects expression ISO RGD:619800 6480464 Ammonium Chloride affects the expression of VEGFC mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:732214 6480464 Antirheumatic Agents results in decreased expression of VEGFC mRNA CTD PMID:24449571 arachidonyl-2'-chloroethylamide multiple interactions ISO RGD:732214 6480464 AM 251 inhibits the reaction [arachidonyl-2-chloroethylamide inhibits the reaction [lipopolysaccharide more ... CTD PMID:26467187 aristolochic acid A decreases expression ISO RGD:732214 6480464 aristolochic acid I results in decreased expression of VEGFC mRNA CTD PMID:33212167 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of VEGFC mRNA CTD PMID:19654921 arsane multiple interactions ISO RGD:732214 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of VEGFC mRNA CTD PMID:32525701 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of VEGFC mRNA CTD PMID:19654921 arsenic atom multiple interactions ISO RGD:732214 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of VEGFC mRNA CTD PMID:32525701 arsenous acid decreases expression ISO RGD:732214 6480464 Arsenic Trioxide results in decreased expression of VEGFC mRNA, Arsenic Trioxide results in decreased expression of VEGFC protein CTD PMID:19099632 , PMID:19804631 arsenous acid multiple interactions ISO RGD:732214 6480464 [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of VEGFC mRNA CTD PMID:32645343 arsenous acid increases expression ISO RGD:732214 6480464 Arsenic Trioxide results in increased expression of VEGFC mRNA CTD PMID:26705709 baicalin multiple interactions ISO RGD:619800 6480464 baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA] CTD PMID:34414639 bendroflumethiazide decreases expression ISO RGD:619800 6480464 Bendroflumethiazide results in decreased expression of VEGFC protein CTD PMID:20625077 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of VEGFC mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:732214 6480464 Benzo(a)pyrene results in increased expression of VEGFC mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation ISO RGD:732214 6480464 Benzo(a)pyrene results in decreased methylation of VEGFC promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of VEGFC mRNA CTD PMID:22228805 , PMID:22610609 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732214 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression EXP 6480464 benzo(b)fluoranthene results in increased expression of VEGFC mRNA CTD PMID:26377693 berberine increases expression ISO RGD:732214 6480464 Berberine results in increased expression of VEGFC mRNA CTD PMID:26478571 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:732214 6480464 IL10 protein affects the reaction [Mustard Gas affects the expression of VEGFC mRNA] CTD PMID:16173061 bis(2-chloroethyl) sulfide decreases expression ISO RGD:732214 6480464 Mustard Gas results in decreased expression of VEGFC mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate affects expression ISO RGD:619800 6480464 Diethylhexyl Phthalate affects the expression of VEGFC mRNA CTD PMID:20920545 bisphenol A increases expression ISO RGD:619800 6480464 bisphenol A results in increased expression of VEGFC mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:619800 6480464 bisphenol A results in decreased expression of VEGFC mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:732214 6480464 bisphenol A results in increased expression of VEGFC mRNA CTD PMID:31715268 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VEGFC mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:732214 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VEGFC mRNA CTD PMID:28628672 bisphenol F affects expression EXP 6480464 bisphenol F affects the expression of VEGFC mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:732214 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of VEGFC gene CTD PMID:31601247 BQ 123 multiple interactions ISO RGD:732214 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] more ... CTD PMID:24184161 butanal decreases expression ISO RGD:732214 6480464 butyraldehyde results in decreased expression of VEGFC mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:732214 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VEGFC mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:732214 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VEGFC mRNA CTD PMID:35301059 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide increases expression ISO RGD:619800 6480464 carbonyl sulfide results in increased expression of VEGFC mRNA CTD PMID:19395590 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of VEGFC mRNA CTD PMID:37019170 chlorthalidone decreases expression ISO RGD:619800 6480464 Chlorthalidone results in decreased expression of VEGFC mRNA, Chlorthalidone results in decreased expression of VEGFC protein CTD PMID:20625077 chlorthalidone increases expression ISO RGD:619800 6480464 Chlorthalidone results in increased expression of VEGFC protein CTD PMID:20625077 cobalt dichloride decreases expression ISO RGD:732214 6480464 cobaltous chloride results in decreased expression of VEGFC mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VEGFC mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:732214 6480464 [Chelating Agents binds to Copper] which results in increased expression of VEGFC mRNA more ... CTD PMID:24690739 more ... copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in decreased expression of VEGFC mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:732214 6480464 [Chelating Agents binds to Copper] which results in increased expression of VEGFC mRNA more ... CTD PMID:24690739 more ... crocidolite asbestos increases expression ISO RGD:732214 6480464 Asbestos, Crocidolite results in increased expression of VEGFC mRNA CTD PMID:18687144 cypermethrin decreases expression ISO RGD:619800 6480464 cypermethrin results in decreased expression of VEGFC mRNA CTD PMID:22528246 cytarabine multiple interactions ISO RGD:732214 6480464 EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine], PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] CTD PMID:24184161 cytarabine multiple interactions EXP 6480464 EDN1 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine], PTGS2 mutant form affects the reaction [VEGFC protein results in decreased susceptibility to Cytarabine] CTD PMID:24184161 cytarabine decreases response to substance ISO RGD:732214 6480464 VEGFC protein results in decreased susceptibility to Cytarabine CTD PMID:24184161 cytarabine decreases response to substance EXP 6480464 VEGFC protein results in decreased susceptibility to Cytarabine CTD PMID:24184161 dexamethasone multiple interactions ISO RGD:732214 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VEGFC mRNA CTD PMID:28628672 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of VEGFC mRNA CTD PMID:25912570 dextran sulfate multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFC mRNA CTD PMID:29950665 diarsenic trioxide increases expression ISO RGD:732214 6480464 Arsenic Trioxide results in increased expression of VEGFC mRNA CTD PMID:26705709 diarsenic trioxide multiple interactions ISO RGD:732214 6480464 [BIBR 1532 co-treated with Arsenic Trioxide] affects the expression of VEGFC mRNA CTD PMID:32645343 diarsenic trioxide decreases expression ISO RGD:732214 6480464 Arsenic Trioxide results in decreased expression of VEGFC mRNA, Arsenic Trioxide results in decreased expression of VEGFC protein CTD PMID:19099632 , PMID:19804631 diazinon affects expression ISO RGD:619800 6480464 Diazinon affects the expression of VEGFC mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of VEGFC mRNA CTD PMID:35537566 dieldrin affects expression ISO RGD:619800 6480464 Dieldrin affects the expression of VEGFC mRNA CTD PMID:22546817 dimethylarsinic acid increases expression EXP 6480464 Cacodylic Acid results in increased expression of VEGFC mRNA CTD PMID:17441966 dioxygen multiple interactions ISO RGD:732214 6480464 Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFC mRNA] CTD PMID:24292262 dioxygen increases expression ISO RGD:732214 6480464 Oxygen deficiency results in increased expression of VEGFC mRNA CTD PMID:24292262 , PMID:26516004 disodium selenite increases expression ISO RGD:732214 6480464 Sodium Selenite results in increased expression of VEGFC mRNA CTD PMID:24383545 disulfiram multiple interactions ISO RGD:732214 6480464 [Disulfiram binds to Copper] which results in increased expression of VEGFC mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:732214 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VEGFC mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:732214 6480464 VEGFC protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:732214 6480464 Doxorubicin results in decreased expression of VEGFC mRNA CTD PMID:29803840 etoposide multiple interactions ISO RGD:732214 6480464 EDN1 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Etoposide], PTGS2 mutant form inhibits the reaction [VEGFC protein results in decreased susceptibility to Etoposide] CTD PMID:24184161 etoposide decreases response to substance ISO RGD:732214 6480464 VEGFC protein results in decreased susceptibility to Etoposide CTD PMID:24184161 flutamide increases expression ISO RGD:619800 6480464 Flutamide results in increased expression of VEGFC mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of VEGFC mRNA CTD PMID:22206623 folic acid increases expression EXP 6480464 Folic Acid results in increased expression of VEGFC protein CTD PMID:25912570 fonofos increases methylation ISO RGD:732214 6480464 Fonofos results in increased methylation of VEGFC promoter CTD PMID:22847954 formaldehyde increases expression ISO RGD:732214 6480464 Formaldehyde results in increased expression of VEGFC mRNA CTD PMID:25617811 fulvestrant multiple interactions ISO RGD:732214 6480464 [bisphenol F co-treated with Fulvestrant] results in decreased methylation of VEGFC gene CTD PMID:31601247 furosemide increases expression ISO RGD:619800 6480464 Furosemide results in increased expression of VEGFC mRNA CTD PMID:16526316 genistein decreases expression ISO RGD:732214 6480464 Genistein results in decreased expression of VEGFC mRNA CTD PMID:22228119 gentamycin increases expression ISO RGD:619800 6480464 Gentamicins results in increased expression of VEGFC mRNA CTD PMID:33387578 glycidol decreases expression ISO RGD:619800 6480464 glycidol results in decreased expression of VEGFC mRNA CTD PMID:24915197 hexaconazole decreases expression EXP 6480464 hexaconazole results in decreased expression of VEGFC mRNA CTD PMID:22045034 hexane decreases methylation ISO RGD:619800 6480464 n-hexane results in decreased methylation of VEGFC promoter CTD PMID:23740543 hydrogen chloride increases expression ISO RGD:732214 6480464 Hydrochloric Acid results in increased expression of VEGFC mRNA CTD PMID:15046208 indometacin multiple interactions ISO RGD:732214 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of VEGFC mRNA CTD PMID:28628672 isotretinoin decreases expression ISO RGD:732214 6480464 Isotretinoin results in decreased expression of VEGFC mRNA CTD PMID:15982314 lipopolysaccharide multiple interactions ISO RGD:732214 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of VEGFC mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:732214 6480464 Lipopolysaccharides results in increased expression of VEGFC mRNA CTD PMID:35811015 losartan decreases expression EXP 6480464 Losartan results in decreased expression of VEGFC mRNA CTD PMID:19771429 maneb multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of VEGFC mRNA CTD PMID:36117858 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of VEGFC mRNA CTD PMID:17467022 methylparaben decreases expression ISO RGD:732214 6480464 methylparaben results in decreased expression of VEGFC mRNA CTD PMID:31745603 methylseleninic acid decreases expression ISO RGD:732214 6480464 methylselenic acid results in decreased expression of VEGFC mRNA CTD PMID:12517777 minocycline multiple interactions ISO RGD:732214 6480464 Minocycline inhibits the reaction [Oxygen deficiency results in increased expression of VEGFC mRNA] CTD PMID:24292262 naringin affects expression ISO RGD:619800 6480464 naringin affects the expression of VEGFC mRNA CTD PMID:24880026 nickel dichloride increases expression ISO RGD:732214 6480464 nickel chloride results in increased expression of VEGFC mRNA CTD PMID:17312168 nickel dichloride affects expression ISO RGD:619800 6480464 nickel chloride affects the expression of VEGFC mRNA CTD PMID:22546817 nimesulide decreases expression ISO RGD:732214 6480464 nimesulide results in decreased expression of VEGFC mRNA, nimesulide results in decreased expression of VEGFC protein CTD PMID:18509974 NS-398 multiple interactions ISO RGD:732214 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] more ... CTD PMID:24184161 organoselenium compound multiple interactions ISO RGD:732214 6480464 [Organoselenium Compounds binds to Copper] which results in decreased expression of VEGFC mRNA CTD PMID:25167922 oxaliplatin increases expression ISO RGD:732214 6480464 oxaliplatin results in increased expression of VEGFC protein CTD PMID:18790786 oxaliplatin increases expression ISO RGD:619800 6480464 oxaliplatin results in increased expression of VEGFC mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:619800 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VEGFC mRNA CTD PMID:25729387 ozone increases expression ISO RGD:732214 6480464 Ozone results in increased expression of VEGFC mRNA CTD PMID:31476115 ozone decreases expression ISO RGD:619800 6480464 Ozone results in decreased expression of VEGFC mRNA CTD PMID:26667334 p-menthan-3-ol decreases expression ISO RGD:732214 6480464 Menthol results in decreased expression of VEGFC mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO RGD:732214 6480464 VEGFC mRNA results in increased susceptibility to [Paclitaxel co-treated with Epirubicin co-treated with CMF regimen] CTD PMID:23146280 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of VEGFC mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:619800 6480464 Acetaminophen results in increased expression of VEGFC mRNA CTD PMID:33387578 paraquat multiple interactions EXP 6480464 [Maneb co-treated with Paraquat] results in decreased expression of VEGFC mRNA CTD PMID:36117858 parathion increases methylation ISO RGD:732214 6480464 Parathion results in increased methylation of VEGFC promoter CTD PMID:22847954 PD 0325901 multiple interactions ISO RGD:732214 6480464 [(+)-JQ1 compound co-treated with mirdametinib] results in decreased expression of VEGFC mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:732214 6480464 mirdametinib results in decreased expression of VEGFC mRNA CTD PMID:25119042 PhIP multiple interactions ISO RGD:619800 6480464 [2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine co-treated with Azoxymethane] results in increased expression of VEGFC mRNA CTD PMID:18424890 prostaglandin E2 decreases expression ISO RGD:732214 6480464 Dinoprostone results in decreased expression of VEGFC mRNA, Dinoprostone results in decreased expression of VEGFC protein CTD PMID:18509974 rotenone increases expression ISO RGD:732214 6480464 Rotenone results in increased expression of VEGFC mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:732214 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of VEGFC mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:732214 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of VEGFC mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:732214 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VEGFC mRNA CTD PMID:27188386 sildenafil citrate increases expression ISO RGD:619800 6480464 Sildenafil Citrate results in increased expression of VEGFC mRNA CTD PMID:20583517 silicon dioxide increases expression ISO RGD:732214 6480464 Silicon Dioxide analog results in increased expression of VEGFC mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:732214 6480464 Silicon Dioxide analog results in decreased expression of VEGFC mRNA CTD PMID:23806026 sodium arsenate multiple interactions ISO RGD:732214 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of VEGFC mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO RGD:732214 6480464 sodium arsenite results in decreased expression of VEGFC mRNA CTD PMID:34032870 sodium dodecyl sulfate increases expression ISO RGD:732214 6480464 Sodium Dodecyl Sulfate results in increased expression of VEGFC mRNA CTD PMID:25617811 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of VEGFC mRNA CTD PMID:27862939 streptozocin decreases expression ISO RGD:619800 6480464 Streptozocin results in decreased expression of VEGFC mRNA CTD PMID:34414639 streptozocin multiple interactions ISO RGD:619800 6480464 baicalin inhibits the reaction [Streptozocin results in decreased expression of VEGFC mRNA] CTD PMID:34414639 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of VEGFC mRNA CTD PMID:21641980 sulprostone increases expression ISO RGD:732214 6480464 sulprostone results in increased expression of VEGFC mRNA CTD PMID:20335389 sunitinib decreases expression ISO RGD:732214 6480464 sunitinib results in decreased expression of VEGFC protein CTD PMID:18669461 sunitinib increases expression ISO RGD:732214 6480464 Sunitinib results in increased expression of VEGFC mRNA CTD PMID:31533062 tebuconazole decreases expression ISO RGD:732214 6480464 tebuconazole results in decreased expression of VEGFC mRNA CTD PMID:26852204 temozolomide decreases expression ISO RGD:732214 6480464 Temozolomide results in decreased expression of VEGFC mRNA CTD PMID:31758290 terbufos increases methylation ISO RGD:732214 6480464 terbufos results in increased methylation of VEGFC promoter CTD PMID:22847954 tert-butyl hydroperoxide increases expression ISO RGD:732214 6480464 tert-Butylhydroperoxide results in increased expression of VEGFC mRNA, tert-Butylhydroperoxide results in increased expression of VEGFC protein CTD PMID:15336504 , PMID:17200665 tert-butyl hydroperoxide increases secretion ISO RGD:732214 6480464 tert-Butylhydroperoxide results in increased secretion of VEGFC protein CTD PMID:17200665 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of VEGFC mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of VEGFC mRNA CTD PMID:31919559 tetrachloromethane increases expression ISO RGD:619800 6480464 Carbon Tetrachloride results in increased expression of VEGFC mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:619800 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of VEGFC mRNA] CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:619800 6480464 Carbon Tetrachloride affects the expression of VEGFC mRNA CTD PMID:12734012 thalidomide affects expression ISO RGD:732214 6480464 Thalidomide affects the expression of VEGFC mRNA CTD PMID:29699374 theophylline increases expression ISO RGD:732214 6480464 Theophylline results in increased expression of VEGFC mRNA CTD PMID:16083514 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of VEGFC mRNA CTD PMID:23557971 , PMID:27760801 titanium dioxide multiple interactions EXP 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of VEGFC mRNA CTD PMID:29950665 topotecan increases expression ISO RGD:619800 6480464 Topotecan results in increased expression of VEGFC mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:619800 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of VEGFC mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:732214 6480464 trichostatin A results in increased expression of VEGFC mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:732214 6480464 Triclosan results in decreased expression of VEGFC mRNA CTD PMID:30510588 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of VEGFC mRNA CTD PMID:28973697 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of VEGFC mRNA CTD PMID:17569031 troglitazone multiple interactions EXP 6480464 [Urethane co-treated with troglitazone] results in increased expression of VEGFC mRNA CTD PMID:18465119 troglitazone decreases expression ISO RGD:732214 6480464 troglitazone results in decreased expression of VEGFC mRNA CTD PMID:20846491 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of VEGFC mRNA CTD PMID:35537566 undecane increases expression ISO RGD:619800 6480464 undecane results in increased expression of VEGFC protein CTD PMID:17337753 urethane multiple interactions EXP 6480464 [Urethane co-treated with troglitazone] results in increased expression of VEGFC mRNA CTD PMID:18465119 urethane increases expression EXP 6480464 Urethane results in increased expression of VEGFC mRNA CTD PMID:18465119 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of VEGFC mRNA CTD PMID:22045034 valproic acid increases expression ISO RGD:732214 6480464 Valproic Acid results in increased expression of VEGFC mRNA CTD PMID:24935251 valproic acid decreases expression ISO RGD:732214 6480464 Valproic Acid results in decreased expression of VEGFC mRNA CTD PMID:29154799 vincaleukoblastine affects response to substance ISO RGD:732214 6480464 VEGFC protein affects the susceptibility to Vinblastine CTD PMID:16217747 vorinostat increases expression ISO RGD:732214 6480464 vorinostat results in increased expression of VEGFC mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:732214 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VEGFC mRNA CTD PMID:27188386 zinc atom decreases expression ISO RGD:619800 6480464 Zinc results in decreased expression of VEGFC mRNA CTD PMID:17074742 zinc sulfate decreases expression ISO RGD:619800 6480464 Zinc Sulfate results in decreased expression of VEGFC mRNA CTD PMID:17074742 zinc(0) decreases expression ISO RGD:619800 6480464 Zinc results in decreased expression of VEGFC mRNA CTD PMID:17074742
